Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials.

GL, Ceresoli; B, Castagneto; PA, Zucali; A, Favaretto; M, Mencoboni; F, Grossi; F, Grossi; D, Cortinovis; Conte G, Del; A, Ceribelli; A, Bearz; S, Salamina; Vincenzo F, De; F, Cappuzzo; M, Marangolo; V, Torri; A, Santoro

doi:10.1038/sj.bjc.6604442

Public

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials.

Shared by NobleBlocks on Jun 10, 2008 • 12:00 AM UTC

Authors:

Ceresoli GL

Castagneto B

Zucali PA

Abstract

The incidence of malignant pleural mesothelioma (MPM) in elderly patients is increasing. In this study, pooled data from two phase II trials of pemetrexed and carboplatin (PC) as first-line therapy were retrospectively analysed for comparisons between age groups. Patients received pemetrexed 500 mg ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!